BARCELONA— The European Association for the Study of Chronic Liver Failure (EASL-Clif) Consortium is constituted by more than 300 clinical researchers in 116 university hospitals across 28 countries. Since its foundation in 2009, the EASL-Clif Consortium has been devoted to the advancement of knowledge on the pathophysiology, diagnostics, and treatment of cirrhosis.
After the annual meeting of the EASL-Clif Consortium Steering Committee, EF Clif announced the election of two new centers to join the EASL-Clif Consortium in supporting targeted research and collaborative initiatives with the aim to advance knowledge of liver disease and improve the quality of life of patients with cirrhosis. Centro Hospitalar e Universitário de Coimbra, Portugal, and Hospital Universitario Marqués de Valdecillas, Spain, both received this designation based on clinical and research excellence. Dr. João Maddaleno and Dr. José Ignacio Fortea were nominated coordinators for each center, respectively.
Required criteria for nominating centers
General nomination criteria for centers:
• Must be located in Europe
• Must have a strong background in hepatology
• Must have medical facilities for hepatology clinic visits
Nominating centers must submit the following information:
• Presence/absence of inpatient clinic/outpatient clinic/day hospital
• Approximate number of inpatients/outpatients with chronic liver failure visited per year
• Availability of a research laboratory facility
• Availability of an animal facility
• Availability of a biobanking facillity
Nominating Center Coordinators and Principal Investigators must submit the following information:
• Curriculum vitae
• List of publications on chronic liver failure (max. 25)
• Motivation letter
European Foundation for the Study of Chronic Liver Failure
Travessera de Gràcia 11, 7th floor
The European Foundation for the Study of Chronic Liver Failure (EF Clif) is a private nonprofit organization which mission is to promote research and education in hepatic chronic failure with the aim to contribute to improving the quality of life and to increase the survival of patients with liver cirrhosis. Since its foundation in 2009, the European Association for the Study of the Liver (EASL) Chair supports research activities through the EASL-Clif Consortium, a network of more than 100 European university hospitals and more than 300 clinical researchers. The Grifols Chair promotes translational studies across centers throughout Europe and North America within the framework of the European Network for Translational Research (ENTR) with 25 centers and more than 40 investigators.